Skip to main content

Table 1 Patient characteristics

From: A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma

Characteristics

Level 1 (N = 3)

Level 2 (N = 6)

Level 3 (N = 6)

N (%)

Age, y

 Median (range)

59 (65–56)

61 (48–63)

63 (52–68)

62 (48–68)

Gender, n

 Male

1

4

3

8 (53 %)

 Female

2

2

3

7 (47 %)

ECOG performance status, n

 0

2

2

2

6 (40 %)

 1

1

4

4

9 (60 %)

Clinical stage

 IIIA

1

2

2

5 (33 %)

 IIIB

2

4

4

10 (67 %)

Smoking History, n

 Never

2

2

3

7 (47 %)

 Ever

1

4

3

8 (53 %)

 Former

1

2

1

4 (27 %)

 Current

0

2

2

4 (53 %)